02 Mar 2020
Who’s Cooking Dinner? returns for 2022!
Leukaemia UK’s flagship fundraising event, Who’s Cooking Dinner?, will return to The Dorchester, Park Lane on Monday 19th September 2022. This year the event will coincide with Blood Cancer Awareness Month to help go even further to raise awareness of the disease.
This unique event, co-founded by restaurant luminaries Chris Corbin OBE and Peter Gordon, has raised over £7 million for life-saving blood cancer research since its inception in 1999.
For one night only, a constellation of the UK’s most prominent culinary stars, with a host of Michelin awards and accolades between them, take part in this remarkable event to raise money for leukaemia research. For a flavour of this extraordinary night, please click here.
“Who’s Cooking Dinner?” is the question asked by the guests of 20 table hosts, who only discover on the night which chef in the all-star line-up will be expertly creating their four course meal. Each table seats 10 giving a capacity for 200 guests to attend the event. The Grand Auction, following the dinner, gives guests the chance to bid for their favourite chef to cook a bespoke dining experience in their home.
Previous alumni of Who’s Cooking Dinner? have included Rick Stein, Tom Kerridge, Giorgio Locatelli, Clare Smyth, Brett Graham, Jean-Philippe Blondet, Mark Hix, Gordon Ramsey, Angela Hartnett and Marcus Wareing, to name but a few.
We would like to thank all the brilliant chefs, restaurants, The Dorchester, our guests, suppliers and other prize donors who so generously donate their time and resources to make Who’s Cooking Dinner? possible.
Chris Corbin OBE is Leukaemia UK’s Chair of Trustees and one half of the duo Corbin & King who turned The Ivy, Le Caprice, J Sheekey and The Wolseley into London’s most sought-after and prestigious eateries. Chef Peter Gordon is famed for his legendary “fusion food”. Both Peter and Chris’ lives were changed irrevocably due to a leukaemia diagnosis.
In 1990, at the age of 38, Chris was diagnosed with chronic myeloid leukaemia (CML). He received treatment and in 1994 underwent a bone marrow transplant. When Peter’s sister Tracey was diagnosed with leukaemia, he donated his bone marrow to save her life.
Following Chris and Peter’s blood cancer experiences, they felt strongly that more leukaemia and blood cancer research needed to be funded. In 1999, Peter and Chris came together to hold the first Who’s Cooking Dinner? fundraising event and over the years it has raised a phenomenal amount for leukaemia and other blood cancer research. Read an interview with Peter Gordon and Chris Corbin about Who’s Cooking Dinner? in the Evening Standard here.
What does the event fund?
Everyday, 28 people in the UK receive the new that they have leukaemia. It has a devastating impact on their lives, and those around them. Bringing together the leukaemia community, Leukaemia UK accelerates progress through life-changing research, doing everything possible to make sure that the next person with leukaemia has the best possible experience of diagnosis, treatment and care.
Both the charity and hospitality sectors have been devastated by the events of the last few years. For 2022, we approached Hospitality Action, a charity who look after personnel within the hospitality industry, to collaborate on the event, with proceeds raised to be shared between the two charities. Now, more than ever, we need your support.
The money raised from the event enables our researchers to continue to push boundaries to develop kinder and more effective treatments for those whose lives are impacted by a leukaemia diagnosis. Over the years this has resulted in important discoveries that have accelerated progress in diagnosis, treatment and care. To find out more about our most recent research please click here.
Want to get involved?
To find out Who’s Cooking Dinner and to purchase a table for this year’s event, please contact Simona at email@example.com
Follow us on Instagram for updates.
11 January 2019
ALL: Investigating a new genetic abnormality
Dr Lisa J Russell, Northern Institute for Cancer Research and John Goldman Fellow
11 January 2019
CLL: Identifying what causes therapy resistance
Dr Adam Linley, University of Liverpool and John Goldman Fellow
11 July 2019
Myeloma: A new treatment strategy?
Dr Sarah Dimeloe, University of Birmingham and John Goldman Fellow
11 January 2019
AML: How do leukaemia cells avoid the Notch pathway?
Dr Fernando dos Anjos Afonso, European Cancer Stem Cell Research Institute, Cardiff and John Goldman Fellow